Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-
BA3261 NUN82647Summary: Inhibits the cell cycle and induces apoptosis in G2 phase. -
BA3262 LY5Summary: LY5 is an inhibitor. -
BA3263 ErbstatinSummary: Erbstatin is an inhibitor of EGFR kinase. -
BA3264 NauclefineSummary: Nauclefine is an indole alkaloid. -
BA3265 DidocosahexaenoinSummary: Didocosahexaenoin, an omega-3 derivative, is a diglyceride of DHA that can be synthesized from DHA triglycerides. -
BA3266 CCT241161Summary: CCT241161 is an orally potent ubiquitous inhibitor. -
BA3267 SFI003Summary: SFI003 is a novel inhibitor. -
BA3269 VPC-70063Summary: VPC-70063 is a potent inhibitor. -
BA3270 Z-LLNle-CHOSummary: Z-LLNle-CHO (Z-Leu-Leu-Nle-CHO) is an inhibitor I. -
BA3271 WJ-39Summary: WJ-39 is an aldose reductase inhibitor with oral activity.


